Results 151 to 160 of about 95,427 (173)

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK. [PDF]

J Int AIDS Soc, 2016
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

External Quantum Efficiency of 6.5% at 300 nm Emission and 4.7% at 310 nm Emission on Bare Wafer of AlGaN-Based UVB LEDs

, 2020
By the Minamata Convention on Mercury, regulation on Mercury use will be stricter from this year of 2020 and safe AlGaN-based ultraviolet (UV) light sources are urgently needed for killing of SARS-...
Muhammad Ajmal Khan, Yuri Itokazu, N. Maeda, Jo Masafumi, Y. Yamada, H. Hirayama   +5 more
semanticscholar   +1 more source

Current-induced degradation and lifetime prediction of 310  nm ultraviolet light-emitting diodes

Photonics Research, 2019
The impact of operation current on the degradation behavior of 310 nm UV LEDs is investigated over 1000 h of stress. It ranges from 50 to 300 mA and corresponds to current densities from 34 to 201  A/cm2.
J. Ruschel, J. Glaab, Batoul Beidoun, N. L. Ploch, J. Rass, T. Kolbe, A. Knauer, M. Weyers, S. Einfeldt, M. Kneissl   +9 more
semanticscholar   +1 more source

Monochromatic electron emission from CeB6 (310) cold field emitter

, 2020
Observation at low voltage using scanning electron microscopes (SEMs) enables the characterization of surface details on specimens on a nanometer scale and is widely used in science and industry. However, the energy width of the electron source restricts
K. Kasuya, T. Kusunoki, T. Hashizume, T. Ohshima, Souichi Katagiri, Y. Sakai, N. Arai   +6 more
semanticscholar   +1 more source

Camrelizumab plus rivoceranib vs sorafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): Final overall survival analysis of the phase 3 CARES-310 study.

Journal of Clinical Oncology
4110 Background: The phase 3 CARES-310 trial is the first to demonstrate significant progression-free survival (PFS) and overall survival (OS) benefits with immunotherapy plus an anti-angiogenic tyrosine kinase inhibitor (TKI) over standard TKI as first ...
Arndt Vogel, S. Chan, Z. Ren, Yuxian Bai, S. Gu, Xiaoyan Lin, Zhendong Chen, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, A. Sultanbaev, Monika Pazgan-Simon, M. Pisetska, Tsz Keung Nip, Haisong Zhang, Jinghua Du, A. Cheng, A. Kaseb, Shukui Qin   +19 more
semanticscholar   +1 more source

Deeply-scaled GaN-on-Si high electron mobility transistors with record cut-off frequency fT of 310 GHz

Applied Physics Express, 2019
A deeply-scaled GaN-on-Si high electron mobility transistor with a record-high cut-off frequency (fT) of 310 GHz has been demonstrated. The device has an InAlN/GaN heterojunction structure, a source–drain spacing of 400 nm, and a gate length of 40 nm ...
Hanlin Xie, Zhihong Liu, Yu Gao, K. Ranjan, K. Lee, G. Ng   +5 more
semanticscholar   +1 more source

Solubility Measurements at 296 and 310 K and Physicochemical Characterization of Abiraterone and Abiraterone Acetate

Journal of Chemical and Engineering Data, 2018
Comparative solubility tests at 296 ± 1 K and 310 ± 1 K in 11 solvents, PAMPA permeability measurements at 296 ± 1 K and 310 ± 1 K in water, FaSSIF-V2 and FeSSIF-V2 media, thermoanalytical investig...
T. Solymosi, F. Tóth, J. Orosz, O. Basa-Dénes, Réka Angi, Tamás Jordán, Zsolt Ötvös, H. Glavinas   +7 more
semanticscholar   +1 more source